Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 622

1.

The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.

Chen SF, Nieh S, Jao SW, Wu MZ, Liu CL, Chang YC, Lin YS.

J Pathol. 2013 Oct;231(2):180-9. doi: 10.1002/path.4226.

PMID:
23775566
2.

Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.

Liu Z, Zhang X, Huang D, Liu Y, Zhang X, Liu L, Li G, Dai Y, Tan H, Xiao J, Tian Y.

Med Oncol. 2012 Dec;29(5):3381-8. doi: 10.1007/s12032-012-0306-9.

PMID:
22815155
3.

The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.

Zhang Z, Yang XF, Huang KQ, Ren L, Zhao S, Gou WF, Shen DF, Sun HZ, Takano Y, Zheng HC.

Tumour Biol. 2016 Feb;37(2):1671-81. doi: 10.1007/s13277-015-3901-5.

PMID:
26311049
4.

Reciprocal interaction between carcinoma-associated fibroblasts and squamous carcinoma cells through interleukin-1α induces cancer progression.

Bae JY, Kim EK, Yang DH, Zhang X, Park YJ, Lee DY, Che CM, Kim J.

Neoplasia. 2014 Nov 20;16(11):928-38. doi: 10.1016/j.neo.2014.09.003.

5.

Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.

Liu CJ, Liu TY, Kuo LT, Cheng HW, Chu TH, Chang KW, Lin SC.

J Pathol. 2008 Mar;214(4):489-97. doi: 10.1002/path.2306.

PMID:
18213732
6.

Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models.

Wheeler SE, Shi H, Lin F, Dasari S, Bednash J, Thorne S, Watkins S, Joshi R, Thomas SM.

Head Neck. 2014 Mar;36(3):385-92. doi: 10.1002/hed.23312.

7.

Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.

Tsujikawa T, Yaguchi T, Ohmura G, Ohta S, Kobayashi A, Kawamura N, Fujita T, Nakano H, Shimada T, Takahashi T, Nakao R, Yanagisawa A, Hisa Y, Kawakami Y.

Int J Cancer. 2013 Jun 15;132(12):2755-66. doi: 10.1002/ijc.27966.

8.

Interleukin-32 expression is associated with a poorer prognosis in head and neck squamous cell carcinoma.

Guenin S, Mouallif M, Hubert P, Jacobs N, Krusy N, Duray A, Ennaji MM, Saussez S, Delvenne P.

Mol Carcinog. 2014 Aug;53(8):667-73. doi: 10.1002/mc.21996.

PMID:
23359495
9.

A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.

Zhou B, Chen WL, Wang YY, Lin ZY, Zhang DM, Fan S, Li JS.

J Oral Pathol Med. 2014 Sep;43(8):585-92. doi: 10.1111/jop.12172.

PMID:
24645915
10.

Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients.

Wang L, Feng Z, Wu H, Zhang S, Pu Y, Bian H, Wang Y, Guo C.

Tumour Biol. 2014 Nov;35(11):10977-85. doi: 10.1007/s13277-014-2392-0.

PMID:
25091574
11.

Bone morphogenetic protein-4-induced epithelial-mesenchymal transition and invasiveness through Smad1-mediated signal pathway in squamous cell carcinoma of the head and neck.

Xu T, Yu CY, Sun JJ, Liu Y, Wang XW, Pi LM, Tian YQ, Zhang X.

Arch Med Res. 2011 Feb;42(2):128-37. doi: 10.1016/j.arcmed.2011.03.003.

PMID:
21565626
12.

Persistent Krüppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma.

Tai SK, Yang MH, Chang SY, Chang YC, Li WY, Tsai TL, Wang YF, Chu PY, Hsieh SL.

Cancer Sci. 2011 Apr;102(4):895-902. doi: 10.1111/j.1349-7006.2011.01859.x.

13.

Fibroblasts and extracellular matrix differently modulate MMP activation by primary and metastatic head and neck cancer cells.

Koontongkaew S, Amornphimoltham P, Monthanpisut P, Saensuk T, Leelakriangsak M.

Med Oncol. 2012 Jun;29(2):690-703. doi: 10.1007/s12032-011-9871-6.

PMID:
21380786
14.

The expression of activin receptor-like kinase 1 among patients with head and neck cancer.

Chien CY, Chuang HC, Chen CH, Fang FM, Chen WC, Huang CC, Huang HY.

Otolaryngol Head Neck Surg. 2013 Jun;148(6):965-73. doi: 10.1177/0194599813479556.

PMID:
23447486
15.

Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models.

Sobral LM, Sousa LO, Coletta RD, Cabral H, Greene LJ, Tajara EH, Gutkind JS, Curti C, Leopoldino AM.

Mol Cancer. 2014 Feb 20;13:32. doi: 10.1186/1476-4598-13-32.

16.

Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.

Menéndez ST, Rodrigo JP, Allonca E, García-Carracedo D, Alvarez-Alija G, Casado-Zapico S, Fresno MF, Rodríguez C, Suárez C, García-Pedrero JM.

J Pathol. 2010 Aug;221(4):402-10. doi: 10.1002/path.2722.

PMID:
20593490
17.

MMP-10/stromelysin-2 promotes invasion of head and neck cancer.

Deraz EM, Kudo Y, Yoshida M, Obayashi M, Tsunematsu T, Tani H, Siriwardena SB, Keikhaee MR, Qi G, Iizuka S, Ogawa I, Campisi G, Lo Muzio L, Abiko Y, Kikuchi A, Takata T.

PLoS One. 2011;6(10):e25438. doi: 10.1371/journal.pone.0025438. Erratum in: PLoS One. 2012;7(2). doi: 10.1371/annotation/ef18e199-e66d-43b9-97e0-96d1ab149193. Kiekhaee, Mohammad Reza [corrected to Keikhaee, Mohammad Reza].

18.

Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells.

Johansson AC, Ansell A, Jerhammar F, Lindh MB, Grénman R, Munck-Wikland E, Östman A, Roberg K.

Mol Cancer Res. 2012 Sep;10(9):1158-68.

19.

FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.

Pattje WJ, Melchers LJ, Slagter-Menkema L, Mastik MF, Schrijvers ML, Gibcus JH, Kluin PM, Hoegen-Chouvalova O, van der Laan BF, Roodenburg JL, van der Wal JE, Schuuring E, Langendijk JA.

Histopathology. 2013 Aug;63(2):263-70. doi: 10.1111/his.12174.

PMID:
23763459
20.

Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma.

Pula B, Jethon A, Piotrowska A, Gomulkiewicz A, Owczarek T, Calik J, Wojnar A, Witkiewicz W, Rys J, Ugorski M, Dziegiel P, Podhorska-Okolow M.

Histopathology. 2011 Dec;59(6):1249-60. doi: 10.1111/j.1365-2559.2011.04060.x.

PMID:
22175904

Supplemental Content

Support Center